ICON-PLC (ICLR) Reports Second Quarter 2013 Revenue of $334 Million, Up 21% Year on Year, Non-GAAP EPS of 43c and Raises FY 2013 Guidance  
7/25/2013 8:13:36 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2013.

Net revenues grew 21% year on year to $334.2 million from $277.0 million in Q2 2012.

Help employers find you! Check out all the jobs and post your resume.